09 January 2020

Burdinola acquires 49% of Burdinola Benelux SRL and takes over 100% control of the Belgian subsidiary

The acquisition of 100% of the subsidiary created in 2017 marks a further step in its internationalisation strategy and growth objectives.

Graphic image of the Benelux formed by the countries Belgium, the Netherlands and Luxembourg

Since its creation, the subsidiary has been working in line with Burdinola's global strategy, focusing on positioning itself in safe laboratories and on attracting large projects.

The subsidiary’s growth forecasts for the coming years are positive. It already has an interesting order book of top level customers and sectors, such as UCB Pharma (the leading Belgian pharmaceutical company) and Dow Chemical Company, among others.

“With our Belgian subsidiary, we are looking to position ourselves as a leader in a market/area in which we have good growth forecasts and to consolidate our leadership in Europe by being leaders in the European countries in which we operate. EIn this sense, we believe that our specialisation in safe laboratories brings differentiation and added value to our technical offer”, said Mikel Martínez, CEO of Burdinola.

Burdinola Benelux joins Burdinola's network of subsidiaries in France, Italy, the UK and UAE (Dubai). It also has offices in Mexico, Peru and Colombia, as well as a widespread commercial presence in Spain with 5 branches.